A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's disease. Chatterjee A, Mohapatra J, Sharma M, Jha A, et al. Brain Res 2024 Jul 27:149129. doi: 10.1016/j.brainres.2024.149129.

Read + Share

Amedeo Smart

Independent Medical Education

Chatterjee A, Mohapatra J, Sharma M, Jha A, et al. A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson's disease. Brain Res 2024 Jul 27:149129. doi: 10.1016/j.brainres.2024.149129.
PMID: 39074525